Literature DB >> 20861224

The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention.

Andrea R Daniel1, Angela L Gaviglio, Lauren M Czaplicki, Christopher J Hillard, Daniel Housa, Carol A Lange.   

Abstract

Progesterone receptors (PRs) are critical regulators of mammary gland development and contributors to breast cancer progression. Posttranslational modifications of PR have been shown to alter hormone responsiveness. Site-directed mutagenesis demonstrated that upon hormone binding, PR is acetylated at the consensus sequence, KXKK (amino acids 638-641), located within the hinge region. We created an acetylation-deficient (K-A) mutant as well as acetylation mimics (K-Q or K-T). Interestingly, similar to K-A PR, PR acetylation mimics (K-Q or K-T) displayed delayed phosphorylation and nuclear entry relative to wild-type (wt) PR-B, indicative of disruption of PR nuclear-cytoplasmic shuttling. Wt PR-B, but not K-mutant PRs, induced c-myc at 1 h of progestin treatment. However, at 6 h of treatment, c-myc induction was comparable with levels induced by wt PR-B, suggesting that the precise timing of PR phosphorylation and nuclear retention are critical for cells to rapidly initiate robust transcriptional programs. In contrast to c-myc, progestin-induced serum- and glucocorticoid-regulated kinase (SGK) expression displayed sensitivity to PR acetylation but not nuclear entry. Namely, in the presence of progestin, acetylation-deficient (K-A) mutant PR-B up-regulated SGK mRNA relative to wt PR; progesterone response element-luciferase assays confirmed this result. However, K-Q and K-T acetylation mimics only weakly induced SGK expression independently of nuclear retention. These data reveal the ability of PR acetylation to alter the magnitude of transcriptional response at selected (slow response) promoters (SGK), whereas the hinge region dictates the kinetics of the transcriptional response to hormone at other (rapid response) promoters (c-myc). In sum, the PR hinge region is multifunctional. Understanding the ability of this region to couple acetylation, phosphorylation, and nuclear entry may provide clues to mechanisms of altered hormone responsiveness.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20861224      PMCID: PMC2958751          DOI: 10.1210/me.2010-0170

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  55 in total

1.  Max is acetylated by p300 at several nuclear localization residues.

Authors:  Francesco Faiola; Yi-Ting Wu; Songqin Pan; Kangling Zhang; Anthony Farina; Ernest Martinez
Journal:  Biochem J       Date:  2007-05-01       Impact factor: 3.857

2.  Transformation of mammalian cells by constitutively active MAP kinase kinase.

Authors:  S J Mansour; W T Matten; A S Hermann; J M Candia; S Rong; K Fukasawa; G F Vande Woude; N G Ahn
Journal:  Science       Date:  1994-08-12       Impact factor: 47.728

3.  Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells.

Authors:  Andrea R Daniel; Emily J Faivre; Carol A Lange
Journal:  Mol Endocrinol       Date:  2007-08-23

4.  p300-mediated acetylation of the Rothmund-Thomson-syndrome gene product RECQL4 regulates its subcellular localization.

Authors:  Tobias Dietschy; Igor Shevelev; Javier Pena-Diaz; Daniela Hühn; Sandra Kuenzle; Raymond Mak; Mohammad Fahad Miah; Daniel Hess; Monika Fey; Michael O Hottiger; Pavel Janscak; Igor Stagljar
Journal:  J Cell Sci       Date:  2009-03-19       Impact factor: 5.285

5.  Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors.

Authors:  Emily J Faivre; Andrea R Daniel; Christopher J Hillard; Carol A Lange
Journal:  Mol Endocrinol       Date:  2008-01-17

Review 6.  Progesterone receptor action: translating studies in breast cancer models to clinical insights.

Authors:  Carol A Lange; Carol A Sartorius; Hany Abdel-Hafiz; Monique A Spillman; Kathryn B Horwitz; Britta M Jacobsen
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

Review 7.  Signaling inputs to progesterone receptor gene regulation and promoter selectivity.

Authors:  Andrea R Daniel; Todd P Knutson; Carol A Lange
Journal:  Mol Cell Endocrinol       Date:  2009-01-20       Impact factor: 4.102

8.  A progesterone receptor co-activator (JDP2) mediates activity through interaction with residues in the carboxyl-terminal extension of the DNA binding domain.

Authors:  Krista K Hill; Sarah C Roemer; David N M Jones; Mair E A Churchill; Dean P Edwards
Journal:  J Biol Chem       Date:  2009-06-24       Impact factor: 5.157

9.  Mechanism of high-mobility group protein B enhancement of progesterone receptor sequence-specific DNA binding.

Authors:  Sarah C Roemer; James Adelman; Mair E A Churchill; Dean P Edwards
Journal:  Nucleic Acids Res       Date:  2008-05-12       Impact factor: 16.971

10.  Quantitative imaging assay for NF-kappaB nuclear translocation in primary human macrophages.

Authors:  Mahdad Noursadeghi; Jhen Tsang; Thomas Haustein; Robert F Miller; Benjamin M Chain; David R Katz
Journal:  J Immunol Methods       Date:  2007-11-20       Impact factor: 2.303

View more
  40 in total

1.  ck2-dependent phosphorylation of progesterone receptors (PR) on Ser81 regulates PR-B isoform-specific target gene expression in breast cancer cells.

Authors:  Christy R Hagan; Tarah M Regan; Gwen E Dressing; Carol A Lange
Journal:  Mol Cell Biol       Date:  2011-04-25       Impact factor: 4.272

Review 2.  Allosteric modulators of steroid hormone receptors: structural dynamics and gene regulation.

Authors:  Raj Kumar; Iain J McEwan
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

3.  Acetylation-mediated epigenetic regulation of glucocorticoid receptor activity: circadian rhythm-associated alterations of glucocorticoid actions in target tissues.

Authors:  Tomoshige Kino; George P Chrousos
Journal:  Mol Cell Endocrinol       Date:  2010-12-10       Impact factor: 4.102

Review 4.  Progesterone receptors, their isoforms and progesterone regulated transcription.

Authors:  Britta M Jacobsen; Kathryn B Horwitz
Journal:  Mol Cell Endocrinol       Date:  2011-09-17       Impact factor: 4.102

Review 5.  Progesterone receptor signaling in the initiation of pregnancy and preservation of a healthy uterus.

Authors:  Margeaux Wetendorf; Francesco J DeMayo
Journal:  Int J Dev Biol       Date:  2014       Impact factor: 2.203

6.  Acquisition of sexual receptivity: roles of chromatin acetylation, estrogen receptor-alpha, and ovarian hormones.

Authors:  Paul J Bonthuis; James K Patteson; Emilie F Rissman
Journal:  Endocrinology       Date:  2011-06-07       Impact factor: 4.736

7.  Lysine deacetylase inhibition attenuates hypertension and is accompanied by acetylation of mineralocorticoid receptor instead of histone acetylation in spontaneously hypertensive rats.

Authors:  Young Mi Seok; Hae Ahm Lee; Kwon Moo Park; Mi-Hyang Hwangbo; In Kyeom Kim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-04-22       Impact factor: 3.000

Review 8.  Progesterone action in breast, uterine, and ovarian cancers.

Authors:  Caroline H Diep; Andrea R Daniel; Laura J Mauro; Todd P Knutson; Carol A Lange
Journal:  J Mol Endocrinol       Date:  2015-01-13       Impact factor: 5.098

Review 9.  Role of phosphorylation in progesterone receptor signaling and specificity.

Authors:  Christy R Hagan; Andrea R Daniel; Gwen E Dressing; Carol A Lange
Journal:  Mol Cell Endocrinol       Date:  2011-09-16       Impact factor: 4.102

Review 10.  Tracking progesterone receptor-mediated actions in breast cancer.

Authors:  Todd P Knutson; Carol A Lange
Journal:  Pharmacol Ther       Date:  2013-11-26       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.